PL2938352T3 - Cykliczne peptydy kationowe o działaniu przeciwdrobnoustrojowym - Google Patents

Cykliczne peptydy kationowe o działaniu przeciwdrobnoustrojowym

Info

Publication number
PL2938352T3
PL2938352T3 PL13828804T PL13828804T PL2938352T3 PL 2938352 T3 PL2938352 T3 PL 2938352T3 PL 13828804 T PL13828804 T PL 13828804T PL 13828804 T PL13828804 T PL 13828804T PL 2938352 T3 PL2938352 T3 PL 2938352T3
Authority
PL
Poland
Prior art keywords
antibmicrobial
activity
cationic peptides
cyclic cationic
cyclic
Prior art date
Application number
PL13828804T
Other languages
English (en)
Inventor
Maria Cristina BARONI
Clotilde Silvia CABASSI
Antonello Romani
Original Assignee
I.C.F. S.R.L.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48048776&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2938352(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by I.C.F. S.R.L. filed Critical I.C.F. S.R.L.
Publication of PL2938352T3 publication Critical patent/PL2938352T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL13828804T 2012-12-28 2013-12-30 Cykliczne peptydy kationowe o działaniu przeciwdrobnoustrojowym PL2938352T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IT002263A ITMI20122263A1 (it) 2012-12-28 2012-12-28 Nuovi peptidi cationici ciclici ad attività antimicrobica
US201361901680P 2013-11-08 2013-11-08
EP13828804.8A EP2938352B1 (en) 2012-12-28 2013-12-30 Cyclic cationic peptides with antibmicrobial activity
PCT/IB2013/002893 WO2014102596A2 (en) 2012-12-28 2013-12-30 New cyclic cationic peptides with antimicrobial activity

Publications (1)

Publication Number Publication Date
PL2938352T3 true PL2938352T3 (pl) 2019-02-28

Family

ID=48048776

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13828804T PL2938352T3 (pl) 2012-12-28 2013-12-30 Cykliczne peptydy kationowe o działaniu przeciwdrobnoustrojowym

Country Status (10)

Country Link
US (1) US10421782B2 (pl)
EP (1) EP2938352B1 (pl)
AU (1) AU2013369042B2 (pl)
CA (1) CA2896697A1 (pl)
DK (1) DK2938352T3 (pl)
ES (1) ES2683392T3 (pl)
IT (1) ITMI20122263A1 (pl)
PL (1) PL2938352T3 (pl)
SI (1) SI2938352T1 (pl)
WO (1) WO2014102596A2 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3298025B1 (en) * 2015-05-19 2026-02-11 Università degli Studi di Parma New amino acid sequences with microbicidal activity derived from naja atra cardiotoxin 1 (ctx-1)
KR20180090785A (ko) 2015-10-07 2018-08-13 아펠리스 파마슈티컬스 인코포레이티드 투여 요법
BR112019020955A2 (pt) * 2017-04-07 2020-05-05 Apellis Pharmaceuticals, Inc. regimes de dosagem e composições e métodos relacionados
IT201700114664A1 (it) * 2017-10-11 2019-04-11 Univ Degli Studi Di Parma Composizioni antibatteriche ad attività potenziata
JP2021507884A (ja) 2017-12-15 2021-02-25 アペリス・ファーマシューティカルズ・インコーポレイテッドＡｐｅｌｌｉｓ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ，Ｉｎｃ． 投与レジメンならびに関連組成物および方法
CN113750248B (zh) * 2021-09-24 2024-01-26 赣南医学院 病理识别分子-药物偶合物及其应用
WO2023092733A1 (zh) * 2021-11-25 2023-06-01 苏州慧疗生物医药科技有限公司 一种用于有效递送核酸的环状多肽载体及其变化形式
CN114989254B (zh) * 2022-06-17 2023-11-03 中山大学 一种多肽及其设计方法和在制备抑制具核梭杆菌产品或预防结直肠癌药物中的应用
CN115572324B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-缬-缬-丙-亮-苯丙肽及制备方法
CN115636869B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环cyclo色苏酪异亮苯丙肽及制备方法
CN116023443B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-丝-缬-亮-亮肽及制备方法
CN115651067B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-丙-缬-异亮-亮肽及制备方法
CN115716864B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-缬-缬-亮-亮肽及制备方法
CN115651068B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-丙-酪-异亮-苯丙肽及制备方法
CN115536734B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-丙-缬-亮-亮肽及制备方法
CN115636870B (zh) * 2022-11-24 2024-04-30 安徽农业大学 具有肝癌细胞毒性和α-葡萄糖苷酶抑制活性的环色-苏-缬-亮-亮肽及制备方法
CN116514925B (zh) * 2023-06-15 2025-11-04 南京农业大学 一种抗结核分枝杆菌的多肽、制备方法及其应用
CN116987149B (zh) * 2023-06-15 2025-11-11 南京农业大学 一种具有抗结核分枝杆菌活性的多肽、制备方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6307016B1 (en) * 1995-07-06 2001-10-23 Intrabiotics Pharmaceuticals, Inc. Parevins and tachytegrins
JPH11509842A (ja) * 1995-07-06 1999-08-31 イントラバイオティクス ファーマシューティカルズ，インコーポレーテッド パレビン及びタキテグリン
AUPP051497A0 (en) 1997-11-24 1997-12-18 University Of Melbourne, The Antimicrobial peptides
US6538155B1 (en) 1999-03-03 2003-03-25 Steven A. Melman Method for preparing an EDTA-Tris composition, a composition containing EDTA-Tris and uses therefor
US20030147906A1 (en) * 1999-07-21 2003-08-07 Smithkline Beecham Biologicals, S.A. Epitopes or mimotopes derived from the C-epsilon-3 or C-epsilon-4 domains of lgE, antagonists thereof, and their therapeutic uses
JP2005519595A (ja) * 2002-03-01 2005-07-07 ダイアックス、コープ モジュラーリコンビナトリアルディスプレイライブラリー
SE0201863D0 (en) * 2002-06-18 2002-06-18 Cepep Ab Cell penetrating peptides
US7271239B2 (en) 2004-09-01 2007-09-18 The Research Foundation Of State University Of New York D-isomers of antimicrobial peptide
US8906364B2 (en) 2005-07-01 2014-12-09 Kane Biotech Inc. Antimicrobial compositions and uses thereof
DE102007044093A1 (de) 2007-09-14 2009-03-19 Phenion Gmbh & Co. Kg Nukleinsäurehaltige kosmetische und/oder pharmazeutische Zubereitungen zur Induktion antimikrobieller Peptide in epithelialen Deckgeweben

Also Published As

Publication number Publication date
AU2013369042A1 (en) 2015-07-16
ITMI20122263A1 (it) 2014-06-29
DK2938352T3 (en) 2018-08-20
ES2683392T3 (es) 2018-09-26
US10421782B2 (en) 2019-09-24
SI2938352T1 (sl) 2018-10-30
WO2014102596A3 (en) 2014-08-21
CA2896697A1 (en) 2014-07-03
EP2938352A2 (en) 2015-11-04
EP2938352B1 (en) 2018-06-20
US20160083427A1 (en) 2016-03-24
AU2013369042B2 (en) 2017-10-05
WO2014102596A2 (en) 2014-07-03

Similar Documents

Publication Publication Date Title
IL269983B (en) Improved autoinjector
SI2938352T1 (sl) Ciklični kationski peptidi z antimikrobno aktivnostjo
ZA201408880B (en) Polypeptides having transgalactosylating activity
PL2819744T3 (pl) Układ elektrod
LT2817043T (lt) Patobulintas švirkšto surinkimo mazgas
LT3679922T (lt) Švirkštas
AU345615S (en) Electrode
EP2929800A4 (en) COMB
ZA201409034B (en) Catalysts
ZA201406703B (en) Improved injections
SG11201504373PA (en) Improved bottle
ZA201503127B (en) Peptides
EP2865061A4 (en) CROWN CAP ASSEMBLY
SI2861241T1 (sl) Izboljšani CD31 peptidi
SG10201507721SA (en) CHO-GMT Recombinant Protein Expression
GB201204868D0 (en) Peptides
PT2891663T (pt) Péptidos derivados de psf1
AU348843S (en) Cap
PH32012001136S1 (en) Cap
GB201219601D0 (en) Autoinjector
GB201220328D0 (en) Peptides
GB201211740D0 (en) Peptides
GB201207895D0 (en) Peptides
GB201200509D0 (en) Peptides
PH32012000324S1 (en) Comb